TOFACITINIB NEAPOLIS 5 MG BT 60
Product information
TOFACITINIB NEAPOLIS is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to or are intolerant to methotrexate. It may be used as monotherapy or in combination with methotrexate or other disease-modifying anti-rheumatic drugs.
We are working on other therapeutic areas
Learn more about our medicines
